New United States Pharmaceutical Tariffs Force Sourcing Realignment
New Section 232 tariffs on patented drugs and ingredients require immediate sourcing audits before the September deadline.
Drug Supply Security
Integrity Protocol
Safeguarding the chain of custody for pharmaceutical products prevents the introduction of counterfeit or substandard items into the market. Effective drug supply security relies on standardized protocols for identifying and tracing units at every transfer point. Manufacturers and distributors use unique identifiers to verify the provenance of individual packages before they reach the patient.
This verification step identifies unauthorized diversions or tampering that could compromise patient safety.
Traceability Requirement
Regulatory frameworks mandate the recording of transaction data for every movement of medication through the commercial system. Under drug supply security, every entity in the logistics chain must store information regarding the origin and ownership history of the product. Automated systems capture serial numbers and batch details to create a permanent electronic record.
These records allow for rapid identification of problematic lots during a recall. Standardized data formats enable different software systems to communicate without manual intervention. Precise tracking reduces the likelihood that stolen or adulterated products re-enter the legitimate distribution network.
System Interoperability
Data exchange between manufacturers and pharmacies ensures a flow of information. Compliance with drug supply security standards requires that all participants use compatible technologies. Secure networks protect sensitive commercial data while maintaining the transparency needed for regulatory audits.